Assyro AI

Orange Book product · Generic (ANDA)

CLOCORTOLONE PIVALATE

CLOCORTOLONE PIVALATE

Generic (ANDA)ANDA 206370TE ABRX TARO

At a glance

Apr 21, 2020

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 21, 2020

    6 yr 3 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

CLOCORTOLONE PIVALATE

Strength

0.1%

Dosage form

CREAM

Route

TOPICAL

TE code

AB

Application

ANDA 206370

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of CLOCORTOLONE PIVALATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.